Comparison of Sevikar® and the Combination of Perindopril/Amlodipine on Central Blood Pressure

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2010
Comparison of the combination of amlodipine with an angiotensin receptor blocker or an angiotensin converting inhibitor, on central arterial blood pressure in patients with hypertension and additional risk factors. This is a randomised, double-blind, double-dummy, multicenter study. The duration of active treatment 24 weeks.
Epistemonikos ID: 9ee5f6574de33abea1e10c3c9fe7e66e54cc8f44
First added on: May 05, 2024